Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SALT-HF: Hypertonic Saline in Outpatient Heart Failure
NCT04533997Phase 3Completed
- Sponsor
- Hospital Universitario Puerta de Hierro Majadahonda
- Start
- Jan 2021
- Primary completion
- May 2023
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 3 trial of hypertonic saline in heart failure (HF), sponsored by Hospital Universitario Puerta de Hierro Majadahonda. Started Jan 2021; status: completed.
02
Drugs
hypertonic saline
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT04533997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04533997.